We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BioVectra

News List

Biovectra Inc. Unveils New Logo and Brand contractpharma
June 04, 2021
Biovectra Inc., a global contract development and manufacturing organization, has launched a new logo and brand to align with the growing company’s full suite of expertise and core values.
PhaseBio and BioVectra Enter into Supply Agreement contractpharma
March 12, 2021
PhaseBio Pharmaceuticals, a clinical-stage biotech focused on the development and commercialization of novel therapies for cardiopulmonary diseases, and BioVectra, a global contract development and manufacturing organization (CDMO), have entered a ...
Mallinckrodt to Sell CDMO BioVectra for $250M contractpharma
September 12, 2019
BioVectra will continue to supply an API for Mallinckrodt's specialty brands business under a long-term deal.
Mallinckrodt invests $100M in its BioVectra CDMO en-cphi.cn
March 08, 2019
The Canadian operations plant where Mallinckrodt makes the API for its controversial—and pricey—H.P. Acthar Gel is expanding and getting some Canadian tax dollars to help with the expense.